Isolation and Drug Susceptibility of Candida parapsilosis Sensu Lato and other Species of C. parapsilosis Complex from Patients with Blood Stream Infections and Proposal of a Novel LAMP Identification Method for the Species

Mycopathologia

Volumn 179, Issue 1-2, 2015, Pages 53-62

  Trabasso, Plinio ^a   Matsuzawa, Tetsuhiro ^b   Fagnani, Renata ^a   Muraosa, Yasunori ^c   Tominaga, Kenichiro ^c   Resende, Mariangela Ribeiro ^a   Kamei, Katsuhiko ^c   Mikami, Yuzuru ^c   Schreiber, Angelica Zaninelli ^a   Moretti, Maria Luiza ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF NAGASAKI   (Japan)

^c Chiba University   (Japan)

Author keywords

Antifungal susceptibility; Candida parapsilosis; Candidemia; LAMP; Molecular diagnostic techniques; Mycoses

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; FUNGAL DNA;

ANTIFUNGAL RESISTANCE; CANDIDA; CANDIDEMIA; CANDIDIASIS; DNA SEQUENCE; DRUG EFFECTS; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MORTALITY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY;

ANTIFUNGAL AGENTS; BASE SEQUENCE; CANDIDA; CANDIDEMIA; CANDIDIASIS; DNA, FUNGAL; DRUG RESISTANCE, FUNGAL; FEMALE; FLUCONAZOLE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA;

EID: 84925482172     PISSN: 0301486X     EISSN: 15730832     Source Type: Journal    
DOI: 10.1007/s11046-014-9830-9     Document Type: Article

References (53)

1. Trofa D, Gácser A, Nosanchuk JD. Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev. 2008;21:606–25.
2. Asmundsdottir LR, Erlendsdottir H, Gottfredsson M. Nationwide study of candidemia, antifungal use, and antifungal drug resistance in Iceland, 2000 to 2011. J Clin Microbiol. 2013;51:841–8.
3. Moretti ML, Trabasso P, Lyra L, Fagnani R, Resende MR, de Oliveira Cardoso LG, Schreiber AZ. Is the incidence of candidemia caused by Candida glabrata increasing in Brazil? Five-year surveillance of Candida bloodstream infection in a university reference hospital in southeast Brazil. Med Mycol. 2013;51:225–30.
4. Azevedo AC, Bizerra FC, da Matta DA, de Almeida LP, Rosas R, Colombo AL. In vitro susceptibility of a large collection of Candida strains against fluconazole and voriconazole by using the CLSI disk diffusion assay. Mycopathologia. 2011;171(6):411–6.
5. Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, Marr KA, Pfaller MA, Chang CH, Webster KM. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis. 2009;48(12):1695–703.
6. Colombo AL, Nucci M, Park BJ, Nouér SA, Arthington-Skaggs B, da Matta DA, Warnock D, Morgan J. Brazilian Network Candidemia Study. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol. 2006;44(8):2816–23.
7. Canton E, Pemán J, Quindós G, Eraso E, Miranda-Zapico I, Álvarez M, Merino P, Campos-Herrero I, Marco F, de la Pedrosa EG, Yagüe G, Guna R, Rubio C, Miranda C, Pazos C, Velasco D. FUNGEMYCA Study Group. Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia. Antimicrob Agents Chemother. 2011;55:5590–6.
8. ®) registry, 2004–2008. Diagn Microbiol Infect Dis. 2012;74:323–31.
9. Das I, Nightingale P, Patel M, Jumaas P. Epidemiology, clinical characteristics, and outcome of candidemia; experience in a tertiary referral center in the UK. Int J Infect Dis. 2011;15:759–63.
10. Falagas ME, Roussos N, Vardakas KZ. Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review. Int J Infect Dis. 2010;14(11):e954–66.
11. Oeser C, Vergnano S, Naidoo R, Anthony M, Chang J, Chow P, Clarke P, Embleton N, Kennea N, Pattnayak S, Reichert B, Scorrer T, Tiron I, Watts T, Sharland M, Heath PT. The Neonatal Infection Surveillance Network (neonIN). Neonatal invasive fungal infection in England 2004–2010. Clin Microbiol Infect. 2014;20(9):936–41. doi:10.1111/1469-0691.12578.
12. Juyal D, Sharma M, Pal S, Rathaur VK, Sharma N. Emergence of non-albicans Candida species in neonatal candidemia. N Am J Med Sci. 2013;5:541–5.
13. Dotes J, Prasad PA, Zaoutis T, Roilides E. Epidemiology, risk factors and outcome of Candida parapsilosis bloodstream infection in children. Pediatr Infect Dis J. 2012;31:557–60.
14. Martino P, Girmenia C, Micozzi A, Raccah R, Gentile G, Venditti M, Mandelli F. Fungemia in patients with leukemia. Am J Med Sci. 1993;306:225–32.
15. Kuhn DM, Mukherjee PK, Clark Ta, et al. Candida parapsilosis characterization in an outbreak setting. Emerg Infect Dis. 2004;10:1074–81.
16. Levin AS, Costa SF, Mussi NS, et al. Candida parapsilosis fungemia associated with implantable and semi-implantable central venous catheter and the hands of health care workers. Diagn Microbiol Infect Dis. 1998;30:243–9.
17. Tavanti A, Davidson AD, Gow NAR, Maiden MCJ, Odds FC. Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J Clin Microbiol. 2005;43:284–92.
18. Gago S, García-Rodas R, Cuesta I, Mellado E, Alastruey-Izquierdo A. Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis virulence in the non-conventional host Galleria mellonella. Virulence. 2014;5(2):278–85.
19. Sakai K, Trabasso P, Moretti ML, Mikami Y, Kamei K, Gonoi T. Identification of fungal pathogens by visible microarray system in combination with isothermal gene amplification. Mycopathologia. 2014;178(1–2):11–26.
20. Buelow DR, Gu Z, Walsh TJ, Hayden RT. Evaluation of multiplexed PCR and liquid-phase array for identification of respiratory fungal pathogens. Med Mycol. 2012;50(7):775–80.
21. Muraosa Y, Schreiber AZ, Trabasso P, Matsuzawa T, Taguchi H, Moretti ML, Mikami Y, Kamei K. Development of cycling probe-based real-time PCR system to detect Fusarium species and Fusarium solani species complex (FSSC). Int J Med Microbiol. 2014;304(3–4):505–11.
22. Hall L, Wohlfiel S, Roberts GD. Experience with the MicroSeq D2 large-subunit ribosomal DNA sequencing kit for identification of filamentous fungi encountered in the clinical laboratory. J Clin Microbiol. 2004;42(2):622–6.
23. Hung WT, Su SL, Shiu LY, Chang TC. Rapid identification of allergenic and pathogenic molds in environmental air by an oligonucleotide array. BMC Infect Dis. 2011;11:91. doi:10.1186/1471-2334-11-91.
24. Nguyen MH, Wissel MC, Shields RK, Salomoni MA, Hao B, Press EG, Shields RM, Cheng S, Mitsani D, Vadnerkar A, Silveira FP, Kleiboeker SB, Clancy CJ. Performance of Candida real-time polymerase chain reaction, β-d-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis. 2012;54(9):1240–8.
25. Fricke S, Fricke C, Schimmelpfennig C, Oelkrug C, Schönfelder U, Blatz R, Zilch C, Faber S, Hilger N, Ruhnke M, Rodloff AC. A real-time PCR assay for the differentiation of Candida species. J Appl Microbiol. 2010;109(4):1150–8.
26. Souza ARC, Ferreira RC, Goncalves SS, Quindos G, Eraso GQ, Birerra FC, Briones MRS, Colombo AL. Accurate identification of Candida parapsilosis (sensu Lato) by use of mitochondrial DNA and real-time PCR. J Clin Microbiol. 2012;50:2310–4.
27. Mori Y, Kitao M, Tomita N, Notomi T. Real-time turbidimetry of LAMP reaction for quantifying template DNA. J Biochem Biophys Methods. 2004;59(2):145–57.
28. Uemura N, Makimura K, Onozaki M, Otsuka Y, Shibuya Y, Yazaki H, Kikuchi Y, Abe S, Kudo S. Development of a loop-mediated isothermal amplification method for diagnosis Pneumocystis pneumonia. J Med Mycol. 2008;57:50–7.
29. Poon LL, Leung CS, Chan KH, Lee LH, Yuen KY, Guan Y, Peiris JS. Detection of human influenza A viruses by loop-mediated isothermal amplification. J Clin Microbiol. 2005;43:427–30.
30. Endo S, Komori T, Ricci G, Sano A, Yokoyama K, Ohori A, Kamei K, Franco M, Miyaji M, Nishimura K. Detection of gp43 of Paracoccidioides brasiliensis by the loop-mediated isothermal amplification (LAMP) method. FEMS Microbiol Lett. 2004;234:93–7.
31. Iida S, Imai T, Oguri T, Okuzumi K, Yamanaka A, Moretti ML, Nishimura K, Mikami Y. Genetic diversity of the internal transcribed spacers (ITS) and 5.8S rRNA genes among the clinical isolates of Candida parapsilosis in Brazil and Japan Jap. J Med Mycol. 2005;46:133–7.
32. Clinical Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of yeasts; Fourth Informational Supplement. CLSI Document M27-S4. Wayne, PA: Clinical and Laboratory Standards Institute; 2012.
33. Singla N, Gulati N, Kaistha N, Chander J. Candida colonization in urine samples of ICU patients: determination of etiology, antifungal susceptibility testing and evaluation of associated risk factors. Mycopathologia. 2012;174(2):149–55.
34. Lockhart SR, Messer SA, Pfaller MA, Diekema DJ. Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis. J Clin Microbiol. 2008;46:2659–64.
35. Pfaller MA, Diekema DJ, Andes D, Arendrup MC, Brown SD, Lockhart SR, Motyl M, Perlin DS. The CLSI subcommittee for antifungal testing Clinical breakpoints for equinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug Res Updates. 2011;14:164–76.
36. Pfaller MA, Andes D, Arendrup M, Diekema DJ, Espinel-Ingroff A, Alexander BD, Brown SD, Chaturvedi V, Fowler CL, Ghannoum MA, Johnson EM, Knapp CC, Motyl MR, Ostrosky-Zeichner L, Walsh TJ. Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamics, and clinical data as they pertain to the development of species-specific interpretive criteria. Diagn Microbiol Infect Dis. 2011;70:330–43.
37. Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Wild-type Diekema DJ, IC M. distributions and epidemiological cutoff values for posaconazole and voriconazole and Candida spp. as determined by 24-h CLSI broth microdilution. J Clin Microbiol. 2010;49:630–7.
38. Pfaller MA, Andes D, Diekema DJ, Espinel-Ingroff A, Sheehan D. The CLSI subcommittee for antifungal susceptibility testing Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods. Drug Res Updates. 2010;13:180–95.
39. Katsu M, Kidd S, Ando A, Moretti ML, Mikami Y, Nishimura K, Meyer W. The internal transcribed spacers and 5.8S rRNA gene show extensive diversity among isolates of the Cryptococcus neoformans species complex. FEMS Yeast Res. 2004;4:377–88.
40. Tamura M, Watanabe K, Mikami Y, Yazawa K, Nishimura K. Molecular characterization of new clinical isolates of Candida albicans and C. dubliniensis in Japan: analysis reveals a new genotype of C. albicans with group I intron. J Clin Microbiol. 2001;39(12):4309–15.
41. Matsuzawa T, Tanaka R, Horie Y, Gonoi T, Yaguchi T. Development of rapid and specific molecular discrimination methods for pathogenic Emericella species. Nihon Ishinkin Gakkai Zasshi. 2010;51(2):109–16.
42. Silva AP, Miranda IM, Lisboa C, Pina-Vaz C, Rodrigues AG. Prevalence, distribution, and antifungal susceptibility profiles of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis in a tertiary care hospital. Clin Microbiol. 2009;47:2392–7.
43. Wisplinghoff H, Ebbers J, Geurtz L, Stefanik D, Major Y, Edmond MB, Wenzel RP, Seifert H. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities. Clin Microbiol. 2014;43(1):78–81.
44. Brito LR, Guimaraes T, Nucci M, Rosas RC, Paula Almeida L, Da Matta DA, Colombo AL. Clinical and microbiological aspects of candidemia due to Candida parapsilosis in Brazilian tertiary care hospitals. Med Mycol. 2006;44:261–6.
45. Garcia-Effron G, Canton E, Peman J, Dilger A, Romá E, Perlin DS. Epidemiology and echinocandin susceptibility of Candida parapsilosis sensu lato species isolated from bloodstream infections at a Spanish university hospital. J Antimicrob Chemother. 2012;67:2739–48.
46. Pfaller MA, Diekema DJ, Procop GW, Rinaldi MG. Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values. Diagn Microbiol Infect Dis. 2013;77:37–40.
47. Németh T, Tóth A, Szenzenstein J, Horváth P, Nosanchuk JD, Grózer Z, Tóth R, Papp C, Hamari Z, Vágvolgyi C, Gácser A. Characterization of virulence properties in the C. parapsilosis sensu lato species. PLoS ONE. 2013;8:e68704.
48. Kasahara K, Ishikawa H, Sato S, Shimakawa Y, Watanabe K. Development of multiplex loop-mediated isothermal amplification assays to detect medically important yeasts in dairy products. FEMS Microbiol Lett. 2014;357(2):208–16.
49. Ferrari M, Resende M, Sakai K, Muraosa Y, Lyra L, Gonoi T, Mikami Y, Tominaga K, Kamei K, Schreiber A, Trabasso P, Moretti ML. Accurate visual DAN-microarray for the molecular identification of non-albicans Candida species isolated from candidemia episodes. J Clin Microbiol. 2013;51(11):3826–9.
50. Inacio J, Flores O, Spencer-Matrins I. Efficient identification of clinical relevant Candida yeast species by use of an assay combining panfungal loop-mediated isothermal DNA amplification with hybridization to species-specific oligonucleotide probes. J Clin Microbiol. 2008;46:713–29.
51. Hara-Kudo Y, Yoshino M, Kojima T, Ikedo M. Loop-mediated isothermal amplification for the rapid detection of Slamonella. FEMS Micribiol Lett. 2005;255:155–61.
52. Pfaller MA, Andes DR, Diekema DJ, Horn DL, Reboli AC, et al. Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 Patients: data from the Prospective Antifungal Therapy (PATH) Registry 2004–2008. PLoS ONE. 2014;9(7):e101510. doi:10.1371/journal.pone.0101510.
53. Prandini TH, Theodoro RC, Bruder-Nascimento AC, Scheel CM, Bagagli E. Analysis of inteins in the Candida parapsilosis complex for simple and accurate species identification. J Clin Microbiol. 2013;51:2830–6.